Viagene Overview
- Year Founded
-
1987
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$95M
Viagene General Information
Description
Provider of gene manipulation technology for the discovery of anti-infective therapies. The company's gene manipulation technology uses applied proprietary gene transfer technology to develop drugs that allowed therapeutic proteins to be produced directly inside cells.
Contact Information
Corporate Office
- 11055 Roselle Street
- San Diego, CA 92121
- United States
Corporate Office
- 11055 Roselle Street
- San Diego, CA 92121
- United States
Viagene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 25-Apr-1995 | $95M | Completed | Generating Revenue | ||
| 3. IPO | 01-Nov-1993 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series D) | 09-Sep-1991 | $7M | $8M | Completed | Generating Revenue | |
| 1. Early Stage VC | 09-Dec-1987 | $1M | $1M | Completed | Product Development |
Viagene Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | ||
| Chancellor Capital Management | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Fairfield Ventures | Venture Capital | Minority | ||
| Sorrento Associates | Corporate Venture Capital | Minority |
Viagene FAQs
-
When was Viagene founded?
Viagene was founded in 1987.
-
Where is Viagene headquartered?
Viagene is headquartered in San Diego, CA.
-
What industry is Viagene in?
Viagene’s primary industry is Biotechnology.
-
Is Viagene a private or public company?
Viagene is a Private company.
-
What is the current valuation of Viagene?
The current valuation of Viagene is .
-
What is Viagene’s current revenue?
The current revenue for Viagene is .
-
How much funding has Viagene raised over time?
Viagene has raised $26M.
-
Who are Viagene’s investors?
3i Group, Chancellor Capital Management, Domain Associates, Fairfield Ventures, and Sorrento Associates are 5 of 6 investors who have invested in Viagene.
-
When was Viagene acquired?
Viagene was acquired on 25-Apr-1995.
-
Who acquired Viagene?
Viagene was acquired by Chiron (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process